Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/2012
05/16/2012CN102451466A Compound high-speed coagulant and preparation method thereof
05/16/2012CN102451465A Use of SIRT1 in preparation of drugs for prevention of diseases caused by endothelial dysfunction
05/16/2012CN102451464A Bile acid combining agent, serum cholesterase amount reduction agent and method for reducing serum cholesterase amount
05/16/2012CN102451463A Naja naja atra analgesic peptide transdermal preparation
05/16/2012CN102451266A Swine traditional Chinese preparation containing fly maggot protein powder
05/16/2012CN102451185A Metal ion nanocluster composition
05/16/2012CN102450718A Pulse sports beverage and preparation method thereof
05/16/2012CN102153642B Application of protein with function of inhibiting growth of scar fibroblast
05/15/2012US8178662 Isolated AEBP1 genomic polynucleotide fragments from chromosome 7 and their uses
05/15/2012US8178661 Molecules of the card-related protein family and uses thereof
05/15/2012US8178657 Polypeptide sequence involved in the modulation of the immunosuppressive effect of viral proteins
05/15/2012US8178656 Encapsulating therapeutic agent in spider silk fibroin; contolling release of pharmaceutical agents
05/15/2012US8178651 Somatostatin-dopamine chimeric analogs
05/15/2012US8178649 Immunostimulatory compositions and uses thereof
05/15/2012US8178520 Macrocyclic compounds as antiviral agents
05/15/2012US8178508 Methods of stimulating an immune response against prostate specific antigen
05/15/2012US8178507 Method for the modulation of function of transcription factors
05/15/2012US8178504 Gene therapy expression of GHRH for increasing RBC count in subjects
05/15/2012US8178497 Method of treating HIV in drug resistant non plasma viral reservoirs with monomeric DAPTA
05/15/2012US8178495 Therapeutic agents comprising a GLP-1 receptor agonist and elastin-like peptide
05/15/2012US8178494 Modified human growth hormone formulations with an increased serum half-life
05/15/2012US8178493 Method for inducing angiogenesis in a heart of a patient
05/15/2012US8178492 Methods and compositions for modulating adipocyte function
05/15/2012US8178491 Antiviral compounds
05/15/2012US8178490 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
05/15/2012US8178489 Formulation for aviptadil
05/15/2012US8178488 Methods for increasing thermogenic adipocytes
05/15/2012US8178487 Method for providing glutamine
05/15/2012US8178337 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
05/15/2012US8178308 Use of IL-27 agonists to increase interferon-gamma production
05/15/2012US8178108 Methods for expression and purification of recombinant human growth hormone
05/15/2012US8178107 Method of treatment of thrombocytopenia or risk thereof using MPL ligand (thrombopoietin), variants, and fragments thereof
05/15/2012US8178099 administering locally a therapeutic amount of a Sost/Wise antagonist in conjunction with an osteoconductive biocompatible calcium salt scaffold; medical orthopedic or periodontal device; prevents kidney damage
05/15/2012US8178091 Compositions and methods for the treatment of respiratory disorders
05/15/2012US8178090 Recombinant hexose oxidase
05/15/2012US8178088 Antiprotozoal composition
05/15/2012US8178086 Activation of HCV specific T cells
05/15/2012US8178083 Treatment of optic neuritis
05/15/2012US8178082 Methods for up-regulating PAP1 in animals suffering from pancreatic disorders
05/15/2012CA2681922C Zinc finger protein derivatives and methods therefor
05/15/2012CA2640743C Pharmaceutical composition of microspheres for preventing diabetic limb amputation
05/15/2012CA2542726C Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes
05/15/2012CA2529449C Pharmaceutical composition comprising cyclic somatostatin analogues
05/15/2012CA2511849C Stable topical drug delivery compositions comprising a multilamellar liquid crystal phosphatidylcholine carrier
05/15/2012CA2511755C 1-desamino-8-d-arginyl vasopressin analogs
05/15/2012CA2505705C Compositions and methods for the diagnosis and treatment of tumor
05/15/2012CA2496329C Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
05/15/2012CA2493859C Preventive/remedy for arteriosclerosis comprising adiponectin
05/15/2012CA2477593C Chemical igf-i formulation for the treatment and prevention of neurodegenerative diseases
05/15/2012CA2474964C An insulin improving agent containing adiponectin
05/15/2012CA2461730C Novel cyclosporin analog microemulsion preconcentrates
05/15/2012CA2450476C A soluble complex comprising a retroviral surface glycoprotein
05/15/2012CA2448933C A retinoic acid metabolizing cytochrome p450
05/15/2012CA2439452C High-affinity antagonists of elr-cxc chemokines
05/15/2012CA2434237C Glp-1 fusion proteins
05/15/2012CA2368385C Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer
05/15/2012CA2367291C Amplification of cyp24 and uses thereof
05/15/2012CA2365536C Compositions and methods for improved delivery of hydrophobic therapeutic agents
05/15/2012CA2358400C Methods for treating conditions associated with the accumulation of excess extracellular matrix
05/15/2012CA2335098C Protease susceptibility ii
05/15/2012CA2288307C Novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
05/15/2012CA2272842C Humanized anti-cd11a antibodies
05/10/2012WO2012061828A2 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
05/10/2012WO2012061750A2 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
05/10/2012WO2012061736A1 Circulating cytochrome c as biomarker of reperfusion injury and responsiveness to mitochondrial targeted interventions
05/10/2012WO2012061689A2 A new variant of antihemophilic factor viii having increased specific activity
05/10/2012WO2012061681A1 Control and characterization of memory function
05/10/2012WO2012061662A1 Glycomimetic-peptidomimetic inhibitors of e-selectins and cxcr4 chemokine receptors
05/10/2012WO2012061466A2 Methods for treating steatotic disease
05/10/2012WO2012061400A2 Method for reduction of free polysaccharide in polysaccharide-protein vaccines reactions using ion-exchange matrices
05/10/2012WO2012061268A1 Compositions and methods for treating antiphospholipid syndrome
05/10/2012WO2012061129A1 Treatment of gastrointestinal inflammation and psoriasis a
05/10/2012WO2012061113A2 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
05/10/2012WO2012061045A2 Methods and compositions for preserving retinal ganglion cells
05/10/2012WO2012061015A2 L-citrulline supplementation during arginine depletion therapy with arginase
05/10/2012WO2012060832A1 Skin wound healing compositions and methods of use thereof
05/10/2012WO2012060734A1 N-isovaleroyl-l-glutamyl-l-tryptophan as an agent inhibiting the formation of ulcers in the stomach and the duodenum
05/10/2012WO2012060607A2 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same
05/10/2012WO2012060480A1 Antigen peptide for suppressing metastasis, anti-metastatic vaccine including same, composition for suppressing and treating metastasis, and method for screening metastasis-related target materials and metastasis suppressant
05/10/2012WO2012060448A1 Combined pharmaceutical composition as antifungal agent
05/10/2012WO2012059820A1 Temperature sensitive hydrogel and block copolymers
05/10/2012WO2012059764A1 Novel composition comprising glucagon
05/10/2012WO2012059762A1 Novel composition comprising glucagon
05/10/2012WO2012059593A1 Vaccines for preventing meningococcal infections
05/10/2012WO2012059592A1 Compounds for delivering a therapeutic or imaging agent to the brain
05/10/2012WO2012059571A1 USE OF ATOMIC QUANTUM CLUSTERS (AQCs) IN THE PREVENTION OF AUTOIMMUNE DISEASES
05/10/2012WO2012059545A1 Novel endolysin
05/10/2012WO2012059224A1 Immunotherapy against erbb-3 receptor
05/10/2012WO2012059223A1 Methods and vectors for cell immortalisation
05/10/2012WO2012058715A1 Immune-modulating agents and uses therefor
05/10/2012WO2012040295A8 Therapeutic applications of smad7
05/10/2012WO2012032360A3 Novel use
05/10/2012WO2012031103A3 Inhibitors of bcl-2
05/10/2012WO2012027324A3 Treatment for neoplastic diseases
05/10/2012WO2012027200A3 Epitope therapy for infectious diseases
05/10/2012WO2012027065A3 Combination therapy for treatment of disease
05/10/2012WO2012021698A3 Treatment of diabetes with pancreatic endocrine precursor cells
05/10/2012WO2012021578A8 Use of angiotensin- ii (1-7) in cell transplantation and as an agent for preventing/treating norovirus infection
05/10/2012WO2012018907A3 Polypeptides for treating and/or limiting influenza infection
05/10/2012WO2012017439A3 Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
1 ... 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 ... 3163